The rise of the Enterococcus: Beyond vancomycin resistance

Nature Reviews Microbiology

Volumn 10, Issue 4, 2012, Pages 266-278

  Arias, Cesar A ^a,b,c   Murray, Barbara E ^a,b  

^a Center for the Study of Emerging and Reemerging Pathogens   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AGGREGATION SUBSTANCE PROTEIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CYTOLYSIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ENTEROCOCCAL LEUCINE RICH REPEAT CONTAINING PROTEIN; ENTEROCOCCAL POLYSACCHARIDE ANTIGEN; ENTEROCOCCAL SURFACE PROTEIN; GELATINASE; GENTAMICIN; HEMOLYSIN; LINEZOLID; METHIONINE SULPHOXIDE REDUCTASE AB; PATHOGENICITY ISLAND ENCODED REGULATOR PROTEIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; SERINE PROTEINASE; SIGMA FACTOR; SORTASE A; STREPTOMYCIN; THIOL PEROXIDASE; UNCLASSIFIED DRUG; VANCOMYCIN; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CONTAMINATION; CATHETER INFECTION; CLADISTICS; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; GASTROINTESTINAL TRACT; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; INFECTION SENSITIVITY; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTERITIS; ENTEROCOCCUS FAECIUM; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL INTERACTIONS; VANCOMYCIN; VANCOMYCIN RESISTANCE; VIRULENCE FACTORS;

ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; NEGIBACTERIA;

EID: 84858398621     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2761     Document Type: Review

References (151)

1. MacCallum, W. G. & Hastings, T. W. A case of acute endocarditis caused by Micrococcus zymogenes (nov. spec.), with a description of the microorganism. J. Exp. Med. 4, 521-534 (1899).
2. Arias, C. A. & Murray, B. E. Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti Infect. Ther. 6, 637-655 (2008).
3. Arias, C. A. & Murray, B. E. in Harrison's Principles of Internal Medicine (eds Longo, D. L.et al.) 1180-1186 (McGraw Hill, New York, 2011).
4. Hidron, A. I. et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29, 996-1011 (2008).
5. Murray, B. E. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3, 46-65 (1990). (Pubitemid 20078774)
6. Willems, R. J. & van Schaik, W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol. 4, 1125-1135 (2009).
7. Ramsey, A. M. & Zilberberg, M. D. Secular trends of hospitalization with vancomycin-resistant Enterococcus infection in the United States, 2000-2006. Infect. Control Hosp. Epidemiol. 30, 184-186 (2009).
8. Werner, G. et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 13, 19046 (2008).
9. Top, J., Willems, R., van der Velden, S., Asbroek, M. & Bonten, M. Emergence of clonal complex 17 Enterococcus faecium in The Netherlands. J. Clin. Microbiol. 46, 214-219 (2008).
10. Soderblom, T. et al. Alarming spread of vancomycin resistant enterococci in Sweden since 2007. Euro Surveill. 15, pii:19629 (2010).
11. Panesso, D. et al. Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J. Clin. Microbiol. 48, 1562-1569 (2010).
12. Liu, Y., Cao, B., Gu, L. & Wang, H. Molecular characterization of vancomycin-resistant enterococci in a Chinese hospital between 2003 and 2009. Microb. Drug Resist. 17, 449-455 (2011).
13. Eckburg, P. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005). (Pubitemid 40807514)
14. Donskey, C. J. et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343, 1925-1932 (2000). (Pubitemid 32064786)
15. Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332-4341 (2010).
16. Brandl, K. et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455, 804-807 (2008).
17. Kinnebrew, M. A. et al. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 201, 534-543 (2010).
18. Bradley, C. R. & Fraise, A. P. Heat and chemical resistance of enterococci. J. Hosp. Infect. 34, 191-196 (1996). (Pubitemid 26377639)
19. Sydnor, E. R. & Perl, T. M. Hospital epidemiology and infection control in acute-care settings. Clin. Microbiol. Rev. 24, 141-173 (2011).
20. Austin, D. J., Bonten, M. J., Weinstein, R. A., Slaughter, S. & Anderson, R. M. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc. Natl Acad. Sci. USA 96, 6908-6913 (1999). (Pubitemid 29274983)
21. Muto, C. A. et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol. 24, 362-386 (2003). (Pubitemid 36612323)
22. Murray, B. E. et al. Evidence for clonal spread of a single strain of β-lactamse producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J. Infect. Dis. 163, 780-785 (1991).
23. Miranda, A. G., Singh, K. V. & Murray, B. E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J. Clin. Microbiol. 29, 2752-2757 (1991).
24. van Schaik, W. & Willems, R. J. Genome-based insights into the evolution of enterococci. Clin. Microbiol. Infect. 16, 527-532 (2010).
25. Ruiz-Garbajosa, P. et al. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J. Clin. Microbiol. 44, 2220-2228 (2006). (Pubitemid 43902179)
26. Willems, R. J. et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg. Infect. Dis. 11, 821-828 (2005). (Pubitemid 40720841)
27. Werner, G. et al. IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium. BMC Infect. Dis. 11, 80 (2011).
28. van Schaik, W. et al. Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island. BMC Genomics 11, 239 (2010).
29. Galloway-Pena, J. R., Roh, J. H., Latorre, M., Qin, X. & Murray, B. E. Genomic, SNP, and 16S rRNA analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium. PLoS ONE 7, e30187 (2012).
30. Galloway-Pena, J. R., Rice, L. B. & Murray, B. E. Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time. Antimicrob. Agents Chemother. 55, 3272-3277 (2011).
31. Paulsen, I. T. et al. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299, 2071-2074 (2003). (Pubitemid 36383734)
32. Bourgogne, A. et al. Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol. 9, R110 (2008).
33. Hegstad, K., Mikalsen, T., Coque, T. M., Werner, G. & Sundsfjord, A. Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin. Microbiol. Infect. 16, 541-554 (2010).
34. Willems, R. J., Hanage, W. P., Bessen, D. E. & Feil, E. J. Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35, 872-900 (2011).
35. Leavis, H. L. et al. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog. 3, e7 (2007).
36. Nelson, K. E. et al. A catalog of reference genomes from the human microbiome. Science 328, 994-999 (2010).
37. Palmer, K. L. et al. High-quality draft genome sequences of 28 Enterococcus sp. isolates. J. Bacteriol. 192, 2469-2470 (2010).
38. Manson, J. M., Hancock, L. E. & Gilmore, M. S. Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits. Proc. Natl Acad. Sci. USA 107, 12269-12274 (2010).
39. Palmer, K. L., Kos, V. N. & Gilmore, M. S. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr. Opin. Microbiol. 13, 632-639 (2010).
40. Palmer, K. L. & Gilmore, M. S. Multidrug-resistant enterococci lack CRISPR-cas. mBio 1, e00227-10 (2010).
41. Booth, M. C. et al. Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol. Microbiol. 21, 1175-1184 (1996). (Pubitemid 26313244)
42. Segarra, R. A., Booth, M. C., Morales, D. A., Huycke, M. M. & Gilmore, M. S. Molecular characterization of the Enterococcus faecalis cytolysin activator. Infect. Immun. 59, 1239-1246 (1991).
43. Ike, Y., Hashimoto, H. & Clewell, D. B. Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice. Infect. Immun. 45, 528-530 (1984). (Pubitemid 14092635)
44. Park, S. Y. et al. Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b. J. Immunol. 181, 6328-6336 (2008).
45. Waters, C. M., Antiporta, M. H., Murray, B. E. & Dunny, G. M. Role of the Enterococcus faecalis GelE protease in determination of cellular chain length, supernatant pheromone levels, and degradation of fibrin and misfolded surface proteins. J. Bacteriol. 185, 3613-3623 (2003). (Pubitemid 36676428)
46. Thomas, V. C. et al. A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol. Microbiol. 72, 1022-1036 (2009).
47. Qin, X., Singh, K. V., Weinstock, G. M. & Murray, B. E. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 68, 2579-2586 (2000). (Pubitemid 30253829)
48. Pinkston, K. L. et al. The Fsr quorum-sensing system of Enterococcus faecalis modulates surface display of the collagen-binding MSCRAMM Ace through regulation of gelE. J. Bacteriol. 193, 4317-4325 (2011).
49. Mylonakis, E. et al. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect. Immun. 70, 4678-4681 (2002). (Pubitemid 34790982)
50. Mohamed, J. A., Huang, W., Nallapareddy, S. R., Teng, F. & Murray, B. E. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect. Immun. 72, 3658-3663 (2004). (Pubitemid 38697799)
51. Zeng, J., Teng, F. & Murray, B. E. Gelatinase is important for translocation of Enterococcus faecalis across polarized human enterocyte-like T84 cells. Infect. Immun. 73, 1606-1612 (2005). (Pubitemid 40470748)
52. Singh, K. V., Qin, X., Weinstock, G. M. & Murray, B. E. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J. Infect. Dis. 178, 1416-1420 (1998).
53. Sifri, C. D. et al. Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect. Immun. 70, 5647-5650 (2002).
54. Engelbert, M., Mylonakis, E., Ausubel, F. M., Calderwood, S. B. & Gilmore, M. S. Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect. Immun. 72, 3628-3633 (2004). (Pubitemid 38697792)
55. Singh, K. V., Nallapareddy, S. R., Nannini, E. C. & Murray, B. E. Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis. Infect. Immun. 73, 4888-4894 (2005). (Pubitemid 41105645)
56. Thurlow, L. R. et al. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect. Immun. 78, 4936-4943 (2010).
57. Hubble, T. S., Hatton, J. F., Nallapareddy, S. R., Murray, B. E. & Gillespie, M. J. Influence of Enterococcus faecalis proteases and the collagen-binding protein, Ace, on adhesion to dentin. Oral Microbiol. Immunol. 18, 121-126 (2003). (Pubitemid 36604367)
58. Solheim, M., Aakra, A., Snipen, L. G., Brede, D. A. & Nes, I. F. Comparative genomics of Enterococcus faecalis from healthy Norwegian infants. BMC Genomics 10, 194 (2009).
59. Olmsted, S. B., Dunny, G. M., Erlandsen, S. L. & Wells, C. L. A plasmid-encoded surface protein on Enterococcus faecalis augments its internalization by cultured intestinal epithelial cells. J. Infect. Dis. 170, 1549-1556 (1994). (Pubitemid 24369916)
60. Schlievert, P. M. et al. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect. Immun. 66, 218-223 (1998). (Pubitemid 28018823)
61. Waters, C. M. et al. An amino-terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid. Mol. Microbiol. 52, 1159-1171 (2004). (Pubitemid 38916181)
62. Heikens, E., Bonten, M. J. & Willems, R. J. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J. Bacteriol. 189, 8233-8240 (2007). (Pubitemid 350178935)
63. Shankar, N. et al. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect. Immun. 69, 4366-4372 (2001). (Pubitemid 32574434)
64. Leendertse, M. et al. Enterococcal surface protein transiently aggravates Enterococcus faecium-induced urinary tract infection in mice. J. Infect. Dis. 200, 1162-1165 (2009).
65. Heikens, E. et al. Contribution of the enterococcal surface protein Esp to pathogenesis of Enterococcus faecium endocarditis. Microb. Infect. 13, 1185-1190 (2011).
66. Hendrickx, A. P., Willems, R. J., Bonten, M. J. & van Schaik, W. LPxTG surface proteins of enterococci. Trends Microbiol. 17, 423-430 (2009).
67. Nallapareddy, S. R., Weinstock, G. M. & Murray, B. E. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol. Microbiol. 47, 1733-1747 (2003). (Pubitemid 36363352)
68. Nallapareddy, S. R. & Murray, B. E. Ligand-signaled upregulation of Enterococcus faecalis ace transcription, a mechanism for modulating host-E. faecalis interaction. Infect. Immun. 74, 4982-4989 (2006). (Pubitemid 44300416)
69. Liu, Q. et al. The Enterococcus faecalis MSCRAMM ACE binds its ligand by the Collagen Hug model. J. Biol. Chem. 282, 19629-19637 (2007). (Pubitemid 47100065)
70. Singh, K. V., Nallapareddy, S. R., Sillanpaa, J. & Murray, B. E. Importance of the collagen adhesin Ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis. PLoS Pathog. 6, e1000716 (2010).
71. Lebreton, F. et al. ace, which encodes an adhesin in Enterococcus faecalis, is regulated by Ers and is involved in virulence. Infect. Immun. 77, 2832-2839 (2009).
72. Nallapareddy, S. R., Singh, K. V., Sillanpaa, J., Zhao, M. & Murray, B. E. Relative contributions of Ebp pili and the collagen adhesin Ace to host extracellular matrix protein adherence and experimental urinary tract infection by Enterococcus faecalis OG1RF. Infect. Immun. 79, 2901-2910 (2011).
73. Nallapareddy, S. R., Singh, K. V., Okhuysen, P. C. & Murray, B. E. A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect. Immun. 76, 4110-4119 (2008).
74. Brinster, S. et al. Enterococcal leucine-rich repeat-containing protein involved in virulence and host inflammatory response. Infect. Immun. 75, 4463-4471 (2007). (Pubitemid 47378105)
75. Nallapareddy, S. R. et al. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Invest. 116, 2799-2807 (2006). (Pubitemid 44511643)
76. Hendrickx, A. P. et al. Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. Microbiology 154, 3212-3223 (2008).
77. Mandlik, A., Das, A. & Ton-That, H. The molecular switch that activates the cell wall anchoring step of pilus assembly in gram-positive bacteria. Proc. Natl Acad. Sci. USA 105, 14147-14152 (2008).
78. Bourgogne, A., Thomson, L. C. & Murray, B. E. Bicarbonate enhances expression of the endocarditis and biofilm associated pilus locus, ebpR-ebpABC, in Enterococcus faecalis. BMC Microbiol. 10, 17 (2010).
79. Gao, P. et al. Enterococcus faecalis rnjB is required for pilin gene expression and biofilm formation. J. Bacteriol. 192, 5489-5498 (2010).
80. Singh, K. V., Nallapareddy, S. R. & Murray, B. E. Importance of the ebp (endocarditis-and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J. Infect. Dis. 195, 1671-1677 (2007). (Pubitemid 46799225)
81. Tendolkar, P. M., Baghdayan, A. S. & Shankar, N. Putative surface proteins encoded within a novel transferable locus confer a high-biofilm phenotype to Enterococcus faecalis. J. Bacteriol. 188, 2063-2072 (2006). (Pubitemid 43376460)
82. Sillanpaa, J. et al. Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology 154, 3199-3211 (2008).
83. Sillanpaa, J. et al. Characterization of the ebpfm pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection. Virulence 1, 236-246 (2010).
84. AlonsoDeVelasco, E., Verheul, A. F., Verhoef, J. & Snippe, H. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59, 591-603 (1995).
85. Theilacker, C. et al. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect. Immun. 74, 5703-5712 (2006). (Pubitemid 44484554)
86. Thurlow, L. R., Thomas, V. C., Fleming, S. D. & Hancock, L. E. Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion. Infect. Immun. 77, 5551-5557 (2009).
87. Hancock, L. E. & Gilmore, M. S. The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc. Natl Acad. Sci. USA 99, 1574-1579 (2002). (Pubitemid 34136534)
88. Xu, Y., Jiang, L., Murray, B. E. & Weinstock, G. M. Enterococcus faecalis antigens in human infections. Infect. Immun. 65, 4207-4215 (1997). (Pubitemid 27422079)
89. Teng, F., Singh, K. V., Bourgogne, A., Zeng, J. & Murray, B. E. Further characterization of the epa gene cluster and Epa polysaccharides of Enterococcus faecalis. Infect. Immun. 77, 3759-3767 (2009).
90. Teng, F., Jacques-Palaz, K. D., Weinstock, G. M. & Murray, B. E. Evidence that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in Enterococcus faecalis and influences resistance to phagocytic killing of E. faecalis. Infect. Immun. 70, 2010-2015 (2002). (Pubitemid 34242202)
91. Xu, Y., Singh, K. V., Qin, X., Murray, B. E. & Weinstock, G. M. Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect. Immun. 68, 815-823 (2000). (Pubitemid 30056541)
92. Singh, K. V., Lewis, R. J. & Murray, B. E. Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection. J. Infect. Dis. 200, 417-420 (2009).
93. Fabretti, F. et al. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 74, 4164-4171 (2006). (Pubitemid 43993350)
94. Theilacker, C. et al. Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis. Mol. Microbiol. 71, 1055-1069 (2009).
95. Freitas, A. R. et al. Global spread of the hylEfm colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster. Antimicrob. Agents Chemother. 54, 2660-2665 (2010).
96. Laverde Gomez, J. A. et al. A multiresistance megaplasmid pLG1 bearing a hylEfm genomic island in hospital Enterococcus faecium isolates. Int. J. Med. Microbiol. 301, 165-175 (2011).
97. Arias, C. A., Panesso, D., Singh, K. V., Rice, L. B. & Murray, B. E. Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium. Antimicrob. Agents Chemother. 53, 4240-4246 (2009).
98. Rice, L. B. et al. Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model. J. Infect. Dis. 199, 342-349 (2009).
99. Panesso, D. et al. The hylEfm gene in pHylEfm of Enterococcus faecium is not required in pathogenesis of murine peritonitis. BMC Microbiol. 11, 20 (2011).
100. Nannini, E. C., Teng, F., Singh, K. V. & Murray, B. E. Decreased virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experimental endocarditis model. Infect. Immun. 73, 7772-7774 (2005). (Pubitemid 41587685)
101. Choudhury, T., Singh, K. V., Sillanpaa, J., Nallapareddy, S. R. & Murray, B. E. Importance of two Enterococcus faecium loci encoding Gls-like proteins for in vitro bile salts stress response and virulence. J. Infect. Dis. 203, 1147-1154 (2011).
102. Claiborne, A. et al. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38, 15407-15416 (1999).
103. La Carbona, S. et al. Comparative study of the physiological roles of three peroxidases (NADH peroxidase, Alkyl hydroperoxide reductase and Thiol peroxidase) in oxidative stress response, survival inside macrophages and virulence of Enterococcus faecalis. Mol. Microbiol. 66, 1148-1163 (2007). (Pubitemid 350115023)
104. Dunny, G. M., Leonard, B. A. & Hedberg, P. J. Pheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication. J. Bacteriol. 177, 871-876 (1995).
105. Clewell, D. B. & Gawron-Burke, C. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu. Rev. Microbiol. 40, 635-659 (1986).
106. Hamburger, M. & Stein, L. Streptococcus viridans subacute bacterial endocarditis; two week treatment schedule with penicillin. JAMA 149, 542-545 (1952).
107. Eliopoulos, G. M. Aminoglycoside resistant enterococcal endocarditis. Infect. Dis. Clin. North Am. 7, 117-133 (1993). (Pubitemid 23103236)
108. Thauvin, C., Eliopoulos, G. M., Willey, S., Wennersten, C. & Moellering, R. C. Jr. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob. Agents Chemother. 31, 139-143 (1987). (Pubitemid 17011225)
109. Moellering, R. C. Jr & Weinberg, A. N. Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J. Clin. Invest. 50, 2580-2584 (1971).
110. Murray, B. E. β-lactamase-producing enterococci. Antimicrob. Agents Chemother. 36, 2355-2359 (1992).
111. Fontana, R., Ligozzi, M., Pittaluga, F. & Satta, G. Intrinsic penicillin resistance in enterococci. Microb. Drug Resist. 2, 209-213 (1996). (Pubitemid 26249927)
112. Rice, L. B., Carias, L. L., Marshall, S., Rudin, S. D. & Hutton-Thomas, R. Tn5386, a novel Tn916-like mobile element in Enterococcus faecium D344R that interacts with Tn916 to yield a large genomic deletion. J. Bacteriol. 187, 6668-6677 (2005). (Pubitemid 41356239)
113. Sauvage, E. et al. The 2.4-Å crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin. Cell. Mol. Life Sci. 59, 1223-1232 (2002).
114. Rybkine, T., Mainardi, J. L., Sougakoff, W., Collatz, E. & Gutmann, L. Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of β-lactam resistance. J. Infect. Dis. 178, 159-163 (1998). (Pubitemid 28328088)
115. Galloway-Pena, J. R., Nallapareddy, S. R., Arias, C. A., Eliopoulos, G. M. & Murray, B. E. Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J. Infect. Dis. 200, 1566-1573 (2009).
116. Chow, J. W. Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 31, 586-589 (2000). (Pubitemid 32289595)
117. Hollingshead, S. & Vapnek, D. Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. Plasmid 13, 17-30 (1985). (Pubitemid 15169412)
118. Krogstad, D. J. et al. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism. J. Clin. Invest. 62, 480-486 (1978). (Pubitemid 8393318)
119. Mingeot-Leclercq, M. P., Glupczynski, Y. & Tulkens, P. M. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43, 727-737 (1999). (Pubitemid 29165732)
120. Galimand, M. et al. Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM. RNA 17, 251-262 (2011).
121. Uttley, A. H., Collins, C. H., Naidoo, J. & George, R. C. Vancomycin-resistant enterococci. Lancet 1, 57-58 (1988). (Pubitemid 18017235)
122. Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319, 157-161 (1988).
123. D'Costa, V. M. et al. Antibiotic resistance is ancient. Nature 477, 457-461 (2011).
124. Swenson, J. M., Facklam, R. R. & Thornsberry, C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob. Agents Chemother. 34, 543-549 (1990). (Pubitemid 20122280)
125. Guardabassi, L., Perichon, B., van Heijenoort, J., Blanot, D. & Courvalin, P. Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob. Agents Chemother. 49, 4227-4233 (2005). (Pubitemid 41400968)
126. Werner, G., Strommenger, B. & Witte, W. Acquired vancomycin resistance in clinically relevant pathogens. Future Microbiol. 3, 547-562 (2008).
127. Arthur, M. & Courvalin, P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37, 1563-1571 (1993). (Pubitemid 23226362)
128. Foucault, M. L., Depardieu, F., Courvalin, P. & Grillot-Courvalin, C. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc. Natl Acad. Sci. USA 107, 16964-16969 (2010).
129. Fantin, B., Leclercq, R., Garry, L. & Carbon, C. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob. Agents Chemother. 41, 931-935 (1997). (Pubitemid 27194163)
130. Harms, J. M., Schlunzen, F., Fucini, P., Bartels, H. & Yonath, A. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin. BMC Biol. 2, 4 (2004).
131. Singh, K. V., Weinstock, G. M. & Murray, B. E. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob. Agents Chemother. 46, 1845-1850 (2002). (Pubitemid 34535206)
132. Kehoe, L. E., Snidwongse, J., Courvalin, P., Rafferty, J. B. & Murray, I. A. Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens. J. Biol. Chem. 278, 29963-29970 (2003). (Pubitemid 36962385)
133. Korczynska, M., Mukhtar, T. A., Wright, G. D. & Berghuis, A. M. Structural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyase. Proc. Natl Acad. Sci. USA 104, 10388-10393 (2007). (Pubitemid 47185675)
134. Leach, K. L. et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol. Cell 26, 393-402 (2007). (Pubitemid 46687101)
135. Wilson, D. N. et al. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc. Natl Acad. Sci. USA 105, 13339-13344 (2008).
136. Boumghar-Bourtchai, L., Dhalluin, A., Malbruny, B., Galopin, S. & Leclercq, R. Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2. Antimicrob. Agents Chemother. 53, 4007-4009 (2009).
137. Lobritz, M., Hutton-Thomas, R., Marshall, S. & Rice, L. B. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrob. Agents Chemother. 47, 3318-3320 (2003). (Pubitemid 37229595)
138. Toh, S. M. et al. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64, 1506-1514 (2007).
139. Arias, C. A. et al. Genetic basis for in vivo daptomycin resistance in enterococci. N. Engl. J. Med. 365, 892-900 (2011).
140. Palmer, K. L., Daniel, A., Hardy, C., Silverman, J. & Gilmore, M. S. Genetic basis for daptomycin resistance in enterococci. Antimicrob. Agents Chemother. 55, 3345-3356 (2011).
141. Hanin, A. et al. Screening of in vivo activated genes in Enterococcus faecalis during insect and mouse infections and growth in urine. PLoS ONE 5, e11879 (2010).
142. Shioya, K. et al. Genome-wide identification of small RNAs in the opportunistic pathogen Enterococcus faecalis V583. PLoS ONE 6, e23948 (2011).
143. Fouquier d'Herouel, A. et al. A simple and efficient method to search for selected primary transcripts: non-coding and antisense RNAs in the human pathogen Enterococcus faecalis. Nucleic Acids Res. 39, e46 (2011).
144. Zaph, C. Which species are in your feces? J. Clin. Invest. 120, 4182-4185 (2010).
145. Jett, B. D., Jensen, H. G., Nordquist, R. E. & Gilmore, M. S. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect. Immun. 60, 2445-2452 (1992).
146. Nallapareddy, S. R. et al. Conservation of Ebp-type pilus genes among Enterococci and demonstration of their role in adherence of Enterococcus faecalis to human platelets. Infect. Immun. 79, 2911-2920 (2011).
147. Guiton, P. S., Hung, C. S., Hancock, L. E., Caparon, M. G. & Hultgren, S. J. Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect. Immun. 78, 4166-4175 (2010).
148. Zhao, C. et al. Role of methionine sulfoxide reductases A and B of Enterococcus faecalis in oxidative stress and virulence. Infect. Immun. 78, 3889-3897 (2010).
149. Coburn, P. S., Baghdayan, A. S., Dolan, G. T. & Shankar, N. An AraC-type transcriptional regulator encoded on the Enterococcus faecalis pathogenicity island contributes to pathogenesis and intracellular macrophage survival. Infect. Immun. 76, 5668-5676 (2008).
150. Hufnagel, M., Koch, S., Creti, R., Baldassarri, L. & Huebner, J. A putative sugar-binding transcriptional regulator in a novel gene locus in Enterococcus faecalis contributes to production of biofilm and prolonged bacteremia in mice. J. Infect. Dis. 189, 420-430 (2004). (Pubitemid 38210578)
151. Le Jeune, A. et al. The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis. PLoS ONE 5, e9658 (2010).